Lupin And YL Secure Japanese Nod For Etanercept

 
• By Grace Montgomery

Lupin and YL Biologics have obtained approval from Japanese regulator PMDA to manufacture and sell biosimilar etanercept in the region. The firm has also just received GMP certification in the EU for its Indian Pune facility where the drug will be produced.

Fukuoka
Lupin and YL Biologics obtain approval for biosimilar etanercept in Japan • Source: Shutterstock

More from Products

More from Generics Bulletin